Abstract
Background
Ventricular fibrillation (VF) is a life‐threatening complication of acute coronary syndrome (ACS) and requires rapid identification and correction of reversible ischemic triggers. ST‐segment elevation in aVR with diffuse ST depression reflects global subendocardial ischemia but is not specific for left main or proximal left anterior descending disease.
Case Summary
A 62‐year‐old male with prior coronary stent placement presented with acute chest pain, diaphoresis, nausea, and vomiting. An electrocardiogram demonstrated ST‐segment elevation in aVR with ST depressions in V3–V6. Laboratory testing demonstrated severe metabolic acidosis (pH 7.07; bicarbonate 10.3 mEq/L), lactate 3.7 mmol/L, and high‐sensitivity troponin rising from 427 to 4991 ng/L within 2 h. During emergent angiography, VF developed after left ventricular catheter manipulation and recurred repeatedly while attempting to cross a heavily calcified 99% proximal left circumflex (LCx) lesion. Over 20–30 min, 11 VF episodes required immediate defibrillation, manual chest compressions, and intravenous amiodarone. VF ceased only after LCx stenting restored TIMI Grade 3 flow. The patient′s maximum intraprocedural shock severity met SCAI Stage E criteria because of recurrent cardiac arrest, multiple defibrillations, and severe acidosis. An Impella microaxial flow pump was placed for temporary postresuscitation circulatory support and maintained at P4. A postreperfusion echocardiogram obtained during ongoing support showed an LVEF of approximately 60%. The device was removed within 48 h after hemodynamic recovery. Staged intravascular lithotripsy‐assisted PCI of the calcified mid‐LAD lesion was performed on Day 4.
Discussion
This case demonstrates that refractory ischemia‐mediated VF may terminate only after culprit‐vessel reperfusion. A preserved LVEF measured after reperfusion during mechanical support does not exclude earlier SCAI Stage E shock. Short‐duration Impella support may serve as an individualized bridge during recovery from recurrent arrest and transient circulatory collapse.
Keywords: acute coronary syndrome, cardiogenic shock, coronary calcification, Impella, intravascular lithotripsy, left circumflex artery, mechanical circulatory support, ventricular fibrillation
Key Insights
Management of a complex case of coronary artery disease with multiple staged interventions.
1. Background
Ventricular fibrillation (VF) is one of the most common causes of sudden cardiac death and remains one of the most catastrophic early complications of acute coronary syndrome (ACS) and acute myocardial infarction [1]. Mehta et al. [2] assessed the incidence and outcomes of ventricular tachycardia/fibrillation in patients undergoing percutaneous coronary intervention (PCI) and found that 329 of 5745 patients (5.7%) experienced an episode of VF or ventricular tachycardia. When VF occurs in the setting of ongoing myocardial ischemia, urgent defibrillation and advanced cardiac life support are crucial to effectively stabilize the patient. In regards to recurrent VF, particularly during coronary angiography or PCI, the underlying etiology is often a persistent ischemic trigger that cannot be definitively treated until restoration of coronary flow is achieved. Effective management often involves rapid recognition and coordination of resuscitation, antiarrhythmic therapy, and ultimately revascularization.
Electrocardiographic patterns are often used to assist in early decision‐making, although sometimes they can be misleading. For example, the presence of ST elevation in lead aVR with diffuse ST‐segment depression is widely recognized as a high‐risk pattern suggestive of global subendocardial ischemia and is frequently appreciated in cases of severe multivessel coronary disease but this finding can also be attributed to left main or proximal left anterior descending (LAD) involvement [3]. However, it is important to understand that this pattern is not specific for an acute left main culprit lesion and may coexist with alternative culprit anatomies. Thus, appreciating this finding on an EKG and anchoring on a presumed left main culprit can result in delayed recognition and treatment of other critical lesions, especially when the culprit resides in territories classically considered to be less arrhythmogenic, such as the left circumflex (LCx) artery. Supporting this concern, Ghanim et al. [4] demonstrated that although the LCx accounted for a similar proportion of obstructive disease as the RCA (27%–29%), it was significantly less often identified as the culprit vessel in ST‐segment–elevation myocardial infarction (STEMI) (17%), suggesting a systematic tendency towards LCx underrecognition in cases of acute infarction.
The updated SCAI SHOCK classification defines Stage E as actual or impending circulatory collapse and lists ongoing resuscitation, multiple defibrillations, profound hypotension, and severe acidosis (pH < 7.2) among its descriptors [5]. Importantly, SCAI stage characterizes the severity and trajectory of shock at a specific time and is not defined by LVEF alone [5].
Temporary mechanical circulatory support with Impella has been used in selected patients with cardiogenic shock to augment systemic perfusion and unload the left ventricle during hemodynamic instability [6, 7]. In recurrent ischemia‐mediated VF, temporary MCS may provide a bridge through electrical and circulatory instability while definitive reperfusion is achieved [5–7]. However, practical case‐based guidance remains limited regarding device initiation and early de‐escalation when postreperfusion ventricular function is preserved.
We report a case of refractory intraprocedural VF with a total of 11 defibrillation episodes during emergent coronary angiography and PCI, with termination of VF only after stenting of a critically stenotic proximal LCx culprit lesion despite an ECG pattern more suggestive of global ischemia. The patient′s maximum intraprocedural shock severity met SCAI Stage E criteria because of recurrent cardiac arrest, multiple defibrillations, and severe acidosis. This case reinforces the importance of rapid culprit identification and reperfusion in ischemia‐driven VF, highlights the diagnostic limitations of aVR elevation, and clarifies why a preserved postreperfusion LVEF does not conflict with an earlier Stage E shock state.
2. Case Presentation
A 62‐year‐old Caucasian male with a past medical history notable for coronary artery disease status post four prior stents, hypertension, hyperlipidemia, and tobacco use presented with acute onset chest pain accompanied by nausea, vomiting, and diaphoresis. Upon arrival to the emergency department (Time 0), the patient was hemodynamically stable. Initial laboratory evaluation was notable for creatinine 1.8 mg/dL, blood urea nitrogen 18 mg/dL, lactate 3.7 mmol/L, and high‐sensitivity troponin 427 ng/L, which increased to 4991 ng/L 2 h later. Electrolytes demonstrated hypokalemia (potassium 3.3 mmol/L). Arterial blood gas revealed severe metabolic acidosis (pH 7.07, bicarbonate 10.3 mEq/L). Initial electrocardiogram demonstrated ST‐segment elevation in aVR with ST depressions in leads V3–V6, consistent with high‐risk ACS and global subendocardial ischemia. The catheterization lab was activated, and the patient was transferred for emergent coronary angiography approximately 30 min after arrival.
Right femoral access was obtained in the catheterization laboratory. During initial left ventricular catheter manipulation to obtain left ventricular end diastolic pressure (LVEDP), the patient developed VF requiring emergent unsynchronized defibrillation with return of spontaneous circulation. Coronary angiography demonstrated a nondominant, highly calcified, diffusely diseased right coronary artery (RCA) measuring < 2.0 mm, not amenable to PCI. The left main coronary artery bifurcated into a severely calcified LAD artery with a focal 80%–90% midsegment stenosis and a LCx artery with a discrete, heavily calcified 99% proximal stenosis, which was identified as the culprit lesion.
During attempts to cross the proximal LCx lesion with a coronary guidewire, the patient developed recurrent VF. Resuscitation was conducted according to advanced cardiac life support guidelines, including immediate unsynchronized defibrillation and manual chest compressions during pulseless intervals. No mechanical chest compression device was used. Intravenous amiodarone was administered; however, the details regarding the cumulative amiodarone dose, specific defibrillation energies, beta‐blocker use, and vasopressor requirements were unavailable for verification in the medical record. Return of spontaneous circulation between episodes permitted wire manipulation and PCI to continue. Over an estimated 20‐ to 30‐min period, the patient experienced 11 VF episodes requiring defibrillation. After successful PCI of the proximal LCx with stent deployment, TIMI Grade 3 flow was restored and VF ceased immediately, supporting persistent ischemia as the primary driver of electrical instability (Figure 1).
Figure 1.

(A, B) Angiographic images before and after PCI demonstrating restoration of TIMI Grade 3 flow in the left circumflex artery.
The patient′s maximum intraprocedural shock severity was SCAI Stage E (extremis), based on recurrent cardiac arrest requiring multiple defibrillations and severe acidosis (pH 7.07) [5]. After TIMI Grade 3 flow was restored, Impella support was initiated due to repeated circulatory collapse and persistent postarrest hemodynamic instability; the device was maintained at P4 (Figure 2). The patient required intubation for acute hypoxic respiratory failure and was managed with lidocaine and cangrelor infusions while remaining in the intensive care unit. A postprocedural echocardiogram obtained after LCx reperfusion, whereas Impella support remained active demonstrated a left ventricular ejection fraction of approximately 60%. Accordingly, the echocardiogram represented postrevascularization ventricular performance measured during ongoing device support and could not define native LV function during the preceding VF episodes.
Figure 2.

Imaging demonstrating the Impella device extending from the left ventricle across the aortic valve into the ascending aorta.
By hospital day 2, the patient′s electrical and hemodynamic instability had resolved, allowing for Impella removal and successful extubation. The patient underwent staged PCI of the LAD on hospital day 4 with intravascular lithotripsy (IVL) followed by drug‐eluting stent placement. He recovered without recurrent ventricular arrhythmia or other major complications and was discharged with close cardiology follow‐up. The clinical course is summarized in Table 1.
Table 1.
Condensed timeline of presentation, revascularization, mechanical support, and recovery.
| Hospital day/phase | Key events | Management | Outcomes |
|---|---|---|---|
| Day 0: ED presentation | Presented with acute chest pain, diaphoresis, and nausea/vomiting. ECG showed ST elevation in aVR with ST depressions in V3–V6. Labs showed myocardial injury and severe metabolic derangement: troponin 427 → 4991 ng/L, lactate 3.7 mmol/L, pH 7.07, HCO3 10.3 mEq/L, K 3.3 mmol/L, Cr 1.8 mg/dL. | Heparin infusion; emergent interventional cardiology evaluation; cath lab activation; electrolyte correction. | High‐risk ACS with severe metabolic derangement identified. |
| Day 0: cath lab | Angiography showed small nondominant diseased RCA, mid‐LAD 80%–90% calcified stenosis, and proximal LCx 99% calcified culprit lesion. Patient developed recurrent intraprocedural VF requiring 11 defibrillations while crossing/treating the LCx. | ACLS/defibrillation; manual compressions; antiarrhythmic therapy; PCI to culprit proximal LCx. | TIMI 3 flow restored and VF ceased after LCx reperfusion, supporting ischemia‐driven VF. |
| Days 0–2: ICU/MCS support | Postarrest physiology consistent with SCAI Stage E shock; required intubation for acute hypoxic respiratory failure. Echocardiography on support showed LVEF ~60%. | Impella support at P4; mechanical ventilation; lidocaine and cangrelor infusions; hemodynamic monitoring. | Shock resolved; Impella removed within 48 h; successfully extubated. |
| Day 4: staged revascularization | Residual severe calcified mid‐LAD 80%–90% stenosis. | Intravascular lithotripsy‐assisted PCI with drug‐eluting stent placement. | Successful LAD revascularization without complication. |
| Discharge/follow‐up | Clinical recovery without recurrent malignant arrhythmia or major complications. | Guideline‐directed post‐PCI therapy; interventional cardiology follow‐up arranged in 2–3 weeks. | Discharged in stable condition. |
3. Discussion
This case highlights an extreme presentation of ACS complicated by refractory intraprocedural VF and SCAI Stage E (extremis) cardiogenic shock. The Stage E designation was based on recurrent circulatory collapse requiring multiple defibrillations and severe acidosis, rather than persistently reduced LVEF [5]. Although ventricular arrhythmias are well‐recognized complications of acute myocardial infarction and PCI, this case is notable for 11 recurrent intraprocedural VF episodes that ceased only after culprit‐vessel reperfusion [2].
An important electrocardiographic teaching point is illustrated in this case. The patient′s ECG demonstrated ST‐segment elevation in aVR with ST depressions in leads V3–V6, a pattern classically associated with left main or proximal LAD disease [3]. However, this pattern is nonspecific and may reflect global subendocardial ischemia, as demonstrated in this case with an LCx culprit lesion [3, 4]. This highlights the risk of anchoring bias and reinforces the need for rapid angiographic evaluation rather than reliance on ECG localization alone.
The apparent paradox of SCAI Stage E shock with preserved LVEF is resolved by the timing and purpose of each assessment. SCAI shock staging is determined by clinical severity and trajectory rather than LVEF alone [5]. The echocardiogram was obtained only after TIMI Grade 3 reperfusion, and while Impella support remained at P4; therefore, it cannot establish whether LV systolic dysfunction was present during the recurrent VF episodes or whether any subsequent recovery occurred. The preserved post‐reperfusion LVEF suggests that the dominant mechanism of collapse was recurrent loss of effective forward flow during VF, compounded by active ischemia and severe acidosis, rather than documented persistent severe LV systolic failure. Transient myocardial stunning is a possible mechanism, but it remains unconfirmed because no presupport quantitative LVEF was available [8]. The immediate cessation of VF after LCx reperfusion and early clinical stabilization support reversal of an ischemia‐mediated electrical and hemodynamic insult, with temporary MCS bridging the postarrest period.
Evidence supporting microaxial flow pumps must be interpreted in context. The DanGer Shock trial demonstrated lower 180‐day mortality in a selected population with STEMI‐related cardiogenic shock defined by hypotension or vasopressor need, lactate ≥ 2.5 mmol/L, and LVEF < 45% [7]. Our patient′s recurrent VF and preserved LVEF seen on the first postreperfusion echocardiogram differ from the population studied in the trial; therefore, direct extrapolation is limited. Observational registry data have associated earlier Impella use with higher survival, but confounding and selection bias limit causal interpretation [6]. In this case, the device was placed after culprit reperfusion as a short‐duration bridge because of recurrent cardiac arrest with repeated circulatory collapse and persistent hemodynamic instability during the early postresuscitation period. This case should therefore be viewed as an individualized rescue strategy rather than evidence supporting routine MCS use in all cases of intraprocedural VF.
Another important aspect of this case is the management of severe coronary calcification, which is associated with adverse PCI outcomes because reduced vessel compliance predisposes to stent underexpansion and malapposition, increasing the risk of restenosis and stent thrombosis [9, 10]. The calcified LAD lesion was therefore treated with IVL during staged PCI. This strategy was selected because conventional noncompliant balloons, even at high pressures, may fail to fracture calcium and can increase the risk of dissection at the calcified–noncalcified interface [9, 10]. Although orbital and rotational atherectomy can facilitate lesion crossing and plaque modification, these techniques carry procedural risks including distal embolization, dissection, and perforation [9, 10]. In this patient recovering from recent electrical and hemodynamic instability, the use of IVL allowed optimal lesion preparation and stent deployment.
This case provides a practical framework for managing ischemia‐driven intraprocedural VF. Successful treatment required simultaneous resuscitation and revascularization, including immediate defibrillation, manual chest compressions during pulseless intervals, antiarrhythmic therapy, continued attempts to cross and reperfuse the culprit lesion during periods of return of spontaneous circulation. No mechanical chest compression device was used. Definitive electrical stability was achieved only after restoration of LCx flow. Temporary MCS was subsequently used as an individualized bridge through the early postarrest period, while hemodynamic stability was established.
4. Conclusion
This case highlights the critical importance of rapid culprit identification and revascularization in ischemia‐driven VF. Refractory VF during PCI may persist until coronary perfusion is restored. This case also demonstrates that a maximum SCAI Stage E shock state can coexist with preserved LVEF measured later, as shock classification is based on the severity of circulatory compromise at the time of circulatory collapse rather than ventricular systolic function alone. Coordinated resuscitation, explicit maintenance and monitoring of perfusion, and individualized short‐duration MCS can bridge selected patients through the early postarrest period.
Additionally, this case illustrates the feasibility of staged IVL‐assisted PCI in managing heavily calcified coronary lesions. Together, these findings provide a practical framework for the management of complex ACS complicated by recurrent VF and transient circulatory collapse.
Nomenclature
- ABG
arterial blood gas
- ACS
acute coronary syndrome
- IVL
intravascular lithotripsy
- LAD
left anterior descending (artery)
- LVEF
left ventricular ejection fraction
- MCS
mechanical circulatory support
- PCI
percutaneous coronary intervention
- RCA
right coronary artery
- SCAI
Society for Cardiovascular Angiography and Interventions
- TIMI
thrombolysis in myocardial infarction
- VF
ventricular fibrillation
Funding
No funding was received for this manuscript.
Disclosure
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Consent
Written informed consent was obtained from the patient for publication of this case.
Conflicts of Interest
The authors declare no conflicts of interest.
Acknowledgments
This research was supported (in whole or in part) by HCA Healthcare and/or an HCA Healthcare affiliated entity. The views expressed in this publication represent those of the author(s) and do not necessarily present the official views of HCA Healthcare or any of its affiliated entities. ChatGPT‐5.5 was used only to assist with language editing, clarity, and manuscript organization. The authors reviewed and verified all AI‐assisted content and take full responsibility for the accuracy, integrity, clinical interpretation, and final content of the manuscript. No artificial intelligence tool was used to generate clinical data, analyze patient information, create images, or make clinical decisions.
Madishetty, Vineet , Yaylayan, Alexander , Schneider, Kevin , Yelamanchili, Varun , Krolick, Merrill , Refractory Intraprocedural Ventricular Fibrillation From Left Circumflex Culprit Occlusion Managed With Culprit PCI and Short‐Duration Impella Support, Case Reports in Cardiology, 2026, 2641470, 6 pages, 2026. 10.1155/cric/2641470
Academic Editor: Satabdi Datta Choudhury
Contributor Information
Vineet Madishetty, Email: vineet.madishetty@hcahealthcare.com.
Satabdi Datta Choudhury, Email: sdattacho@wiley.com.
Data Availability Statement
As a case report, the patient′s individual information is not available for review, in accordance with HIPAA compliance. Prior development and submission of the manuscript, written informed consent was obtained from the patient.
References
- 1. Huikuri H. V., Castellanos A., and Myerburg R. J., Sudden Death due to Cardiac Arrhythmias, New England Journal of Medicine. (2001) 345, no. 20, 1473–1482, 10.1056/NEJMra000650. [DOI] [PubMed] [Google Scholar]
- 2. Mehta R. H., Starr A. Z., Lopes R. D., Hochman J. S., Widimsky P., Pieper K. S., Armstrong P. W., Granger C. B., and APEX AMI Investigators, Incidence of and Outcomes Associated With Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention, Journal of the American Medical Association. (2009) 301, no. 17, 1779–1789, 10.1001/jama.2009.600. [DOI] [PubMed] [Google Scholar]
- 3. Yamaji H., Iwasaki K., Kusachi S., Murakami T., Hirami R., Hamamoto H., Hina K., Kita T., Sakakibara N., and Tsuji T., Prediction of Acute Left Main Coronary Artery Obstruction by 12-Lead Electrocardiography. ST Segment Elevation in Lead aVR With Less ST Segment Elevation in Lead V(1), Journal of the American College of Cardiology. (2001) 38, no. 5, 1348–1354, 10.1016/s0735-1097(01)01563-7, 11691506. [DOI] [PubMed] [Google Scholar]
- 4. Ghanim D., Kusniec F., Kinany W., Qarawani D., Meerkin D., Taha K., Amir O., and Carasso S., Left Circumflex Coronary Artery as the Culprit Vessel in ST-Segment-Elevation Myocardial Infarction, Texas Heart Institute Journal. (2017) 44, no. 5, 320–325, 10.14503/THIJ-16-5905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Naidu S. S., Baran D. A., Jentzer J. C., Hollenberg S. M., van Diepen S., Basir M. B., Grines C. L., Diercks D. B., Hall S., Kapur N. K., Kent W., Rao S. V., Samsky M. D., Thiele H., Truesdell A. G., and Henry T. D., SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This Statement Was Endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021, Journal of the American College of Cardiology. (2022) 79, no. 9, 933–946, 10.1016/j.jacc.2022.01.018, 35115207. [DOI] [PubMed] [Google Scholar]
- 6. O′Neill W. W., Grines C., Schreiber T., Moses J., Maini B., Dixon S. R., and Ohman E. M., Analysis of outcomes for 15,259 US Patients With Acute Myocardial Infarction Cardiogenic Shock (AMICS) Supported With the Impella device, American Heart Journal. (2018) 202, 33–38, 10.1016/j.ahj.2018.03.024, 29803984. [DOI] [PubMed] [Google Scholar]
- 7. Møller J. E., Engstrøm T., Jensen L. O., Eiskjær H., Mangner N., Polzin A., Schulze P. C., Skurk C., Nordbeck P., Clemmensen P., Panoulas V., Zimmer S., Schäfer A., Werner N., Frydland M., Holmvang L., Kjærgaard J., Sørensen R., Lønborg J., Lindholm M. G., Udesen N. L. J., Junker A., Schmidt H., Terkelsen C. J., Christensen S., Christiansen E. H., Linke A., Woitek F. J., Westenfeld R., Möbius-Winkler S., Wachtell K., Ravn H. B., Lassen J. F., Boesgaard S., Gerke O., Hassager C., and DanGer Shock Investigators, Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock, New England Journal of Medicine. (2024) 390, no. 15, 1382–1393, 10.1056/NEJMoa2312572, 38587239. [DOI] [PubMed] [Google Scholar]
- 8. Braunwald E. and Kloner R. A., The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction, Circulation. (1982) 66, no. 6, 1146–1149, 10.1161/01.cir.66.6.1146. [DOI] [PubMed] [Google Scholar]
- 9. Kereiakes D. J., Ali Z. A., Riley R. F., Smith T. D., and Shlofmitz R. A., Intravascular Lithotripsy for Treatment of Calcified Coronary Artery Disease, Interventional Cardiology Clinics. (2022) 11, no. 4, 393–404, 10.1016/j.iccl.2022.02.004. [DOI] [PubMed] [Google Scholar]
- 10. Oliveira C., Vilela M., Nobre Menezes M., Silva Marques J., Jorge C. M., Rodrigues T., Almeida Duarte J., Marques da Costa J., Carrilho Ferreira P., Francisco A. R., Cardoso P. P., and Pinto F. J., Coronary Intravascular Lithotripsy Effectiveness and Safety in a Real-World Cohort, Journal of Personalized Medicine. (2024) 14, no. 4, 10.3390/jpm14040438, 38673064. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
As a case report, the patient′s individual information is not available for review, in accordance with HIPAA compliance. Prior development and submission of the manuscript, written informed consent was obtained from the patient.
